Burton Karen L 4
4 · STERIS plc · Filed Aug 12, 2025
Insider Transaction Report
Form 4
STERIS plcSTE
Burton Karen L
Sr. Vice Pres., CFO
Transactions
- Exercise/Conversion
Ordinary Shares
2025-08-11$114.22/sh+7,900$902,338→ 13,894 total - Sale
Ordinary Shares
2025-08-11$241.73/sh−7,900$1,909,667→ 5,994 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-08-11−7,900→ 0 totalExercise: $114.22Exp: 2028-05-31→ Ordinary Shares (7,900 underlying)
Footnotes (3)
- [F1]Price reflects a weighted average sale price for multiple transactions ranging from $241.33 to $242.32 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]As of August 12, 2025, 3,216 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 86 on October 1, 2025; 340 on June 1, 2026; 651 on June 3, 2026; 225 on June 2, 2026; 306 on June 4, 2026; 651 on June 3, 2027; 306 on June 4, 2027 and 651 on June 5, 2028.
- [F3]This option to purchase 7,900 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 7,900 ordinary shares for $114.22 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.